Literature DB >> 24849376

Basal serum testosterone levels correlate with ovarian response but do not predict pregnancy outcome in non-PCOS women undergoing IVF.

Bo Sun1, Fang Wang, Jing Sun, Wenzhu Yu, Yingpu Sun.   

Abstract

PURPOSE: To evaluate basal testosterone (T) levels in women undergoing in vitro fertilization (IVF) cycles and examine the association between basal T levels and ovarian response or IVF pregnancy outcome.
METHODS: We retrospectively analyzed 1413 infertile Chinese women undergoing their first IVF treatment at our institution's reproductive center from March 2011 to May 2013. The basal testosterone (T) levels in women undergoing in vitro fertilization (IVF) and the relationship between basal T levels and ovarian response or IVF pregnancy outcome were determined. These patients did not have polycystic ovary syndrome (PCOS) or endometriosis, and were treated with a long luteal down-regulation protocol. Subjects were divided into 2 groups according to basal testosterone (T) levels: Group 1, basal T values <20 ng/dl (n = 473), and Group 2, basal T values >20 ng/dl (n = 940). We evaluated the association of basal T levels with ovarian response and IVF outcome in the two groups.
RESULTS: In this study, BMI, basal follicle-stimulating hormone (FSH) levels, basal luteinizing hormone (LH) levels, antral follicle count (AFC), days of stimulation, total gonadotrophin dose, basal FSH/LH ratio, and the number of follicles >14 mm were significantly different (P < 0.05) between the two groups. Basal T level positively correlated with ovarian reserve function, number of follicles >14 mm on human chorionic gonadotrophin (HCG) day, and total gonadotropin dose. However, basal T levels play no role in predicting IVF pregnancy outcome.
CONCLUSION: Basal T level can be used as a good predictor for ovarian response and the number of large follicles on HCG day. Additionally, we may use basal T level as a marker to predict FSH dosage. In general women, lower level of T might relate with potential poor ovarian response. However, based on our data, basal T levels do not predict pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24849376      PMCID: PMC4096887          DOI: 10.1007/s10815-014-0246-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  39 in total

1.  Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study.

Authors:  J Kwee; M W Elting; R Schats; P D Bezemer; C B Lambalk; J Schoemaker
Journal:  Hum Reprod       Date:  2003-07       Impact factor: 6.918

2.  Effect of androgen levels on in vitro fertilization cycles.

Authors:  John L Frattarelli; Elizabeth H Peterson
Journal:  Fertil Steril       Date:  2004-06       Impact factor: 7.329

3.  Embryo scoring as a prognostic tool in IVF treatment.

Authors:  F Puissant; M Van Rysselberge; P Barlow; J Deweze; F Leroy
Journal:  Hum Reprod       Date:  1987-11       Impact factor: 6.918

4.  Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.

Authors:  S Weil; K Vendola; J Zhou; C A Bondy
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

5.  Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production.

Authors:  J Bonser; J Walker; A Purohit; M J Reed; B V Potter; D S Willis; S Franks; H D Mason
Journal:  J Endocrinol       Date:  2000-12       Impact factor: 4.286

6.  Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary.

Authors:  K Vendola; J Zhou; J Wang; O A Famuyiwa; M Bievre; C A Bondy
Journal:  Biol Reprod       Date:  1999-08       Impact factor: 4.285

7.  Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary.

Authors:  K Vendola; J Zhou; J Wang; C A Bondy
Journal:  Hum Reprod       Date:  1999-09       Impact factor: 6.918

8.  Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis.

Authors:  László F J M M Bancsi; Frank J M Broekmans; Ben W J Mol; J Dik F Habbema; Egbert R te Velde
Journal:  Fertil Steril       Date:  2003-05       Impact factor: 7.329

9.  Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.

Authors:  R T Scott; J P Toner; S J Muasher; S Oehninger; S Robinson; Z Rosenwaks
Journal:  Fertil Steril       Date:  1989-04       Impact factor: 7.329

10.  Is there a role for DHEA supplementation in women with diminished ovarian reserve?

Authors:  Mazen R Fouany; Fady I Sharara
Journal:  J Assist Reprod Genet       Date:  2013-06-05       Impact factor: 3.412

View more
  9 in total

1.  Association of basal serum androgen levels with ovarian response and ICSI cycle outcome.

Authors:  C Abide Yayla; E Ozkaya; S Kayatas Eser; I Sanverdi; B Devranoglu; T Kutlu
Journal:  Ir J Med Sci       Date:  2017-07-25       Impact factor: 1.568

2.  Basal serum level of Δ4-androstenedione reflects the ovaries' ability to respond to stimulation in IVF cycles: setting up a new reliable index of both ovarian reserve and response.

Authors:  Emanuele Garzia; Valentina Galiano; Laura Guarnaccia; Giovanni Marfia; Giulia Murru; Ellade Guermandi; Jennifer Riparini; Patrizia Sulpizio; Anna Maria Marconi
Journal:  J Assist Reprod Genet       Date:  2022-06-27       Impact factor: 3.357

3.  Androgenicity and fertility treatment in women with unexplained infertility.

Authors:  Erica T Wang; Michael P Diamond; Ruben Alvero; Peter Casson; Gregory M Christman; Christos Coutifaris; Karl R Hansen; Fangbai Sun; Richard S Legro; Randal D Robinson; Rebecca S Usadi; Margareta D Pisarska; Nanette F Santoro; Heping Zhang
Journal:  Fertil Steril       Date:  2020-03       Impact factor: 7.329

4.  Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome.

Authors:  Selçuk Selçuk; Enis Özkaya; Ahmet Eser; Melda Kuyucu; Hüseyin Tayfun Kutlu; Belgin Devranoğlu; Kenan Sofuoğlu; Vedat Erkan Dayıcıoğlu
Journal:  Turk J Obstet Gynecol       Date:  2016-03-10

5.  Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study).

Authors:  Eser Sefik Ozyurek; Tevfik Yoldemir; Gokhan Artar
Journal:  J Ovarian Res       Date:  2017-05-12       Impact factor: 4.234

6.  Serum testosterone levels are positively associated with serum anti-mullerian hormone levels in infertile women.

Authors:  Li-Te Lin; Chia-Jung Li; Kuan-Hao Tsui
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 7.  The evolutionary biology of endometriosis.

Authors:  Natalie Dinsdale; Pablo Nepomnaschy; Bernard Crespi
Journal:  Evol Med Public Health       Date:  2021-03-12

8.  Hormonal changes in consecutive clomiphene citrate stimulation cycles and their effect on pregnancy rates.

Authors:  Evrim Ebru Kovalak; Eser Şefik Özyürek; Özlem Karabay Akgül; Tolga Karacan
Journal:  Turk J Obstet Gynecol       Date:  2022-09-23

Review 9.  Endometriosis and polycystic ovary syndrome are diametric disorders.

Authors:  Natalie L Dinsdale; Bernard J Crespi
Journal:  Evol Appl       Date:  2021-05-14       Impact factor: 4.929

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.